Vericel (VCEL) Misses Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Vericel Corporation (VCEL) PT Lowered to $45 at BTIG
February 24, 2022 12:54 PM ESTBTIG analyst Ryan Zimmerman lowered the price target on Vericel Corporation (NASDAQ: VCEL) to $45.00 (from $50.00) while maintaining a Buy rating.
The analyst commented, "We maintain our Buy rating but lower our PT to $45 (from $50) as multiples have compressed in high-growth MedTech. VCEL reported 4Q21 revenue of $47.6M (+5.2% Y/Y) which was below BTIG/Consensus original expectations of $50.7M/$51.0M with the... More
